Abbott Laboratories (ABT), Millicom International Cellular (TIGO), Rain Oncology (RAIN), and NeoGames (NGMS) Face Rating Downgrades
- May 30th, 2023
- 532 views
Several companies have experienced downgrades in their ratings today:
Abbott Laboratories (NYSE: ABT), a well-known healthcare company, has been downgraded from Overweight to Equal-Weight by Morgan Stanley.
Currently, $ABT is trading at $101.70, reflecting a decline of $1.17 or 1.06%.
Millicom International Cellular S.A. (Nasdaq: TIGO), a telecommunications and media company operating primarily in Latin America, has experienced a downgrade from Overweight to Equal Weight by Barclays.
$TIGO is trading at $16.82 in intraday, indicating a decrease of $1.16 or 6.48%.
Rain Oncology Inc. (Nasdaq: RAIN), a biopharmaceutical company specializing in cancer therapies, has been downgraded from Buy to Neutral by ROTH MKM.
$RAIN is currently trading at $1.07, reflecting a decline of $0.02 or 2.27%.
NeoGames S.A. (Nasdaq: NGMS), a leading provider of online lottery and scratch games, has experienced a downgrade from Outperform to Neutral by Macquarie.
In intraday, $NGMS is trading at $27.20, down $0.07 or 0.24%.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
CSX, VinFast Auto, and Crown Castle's Earnings Preview
April 14th, 2024Earnings Spotlight: McCormick, TD SYNNEX, and GameStop Set to Report
March 23rd, 2024Upcoming Earnings: Adobe, Ulta Beauty, and Smartsheet Under the Lens
March 10th, 2024
Member Login